Last updated 2026-08-29
- Raised $200M Series B led by L-Bank, May 2024
- Raised $150M Series A, Sep 2023
- Raised $29.7M Series E, Aug 2026
Total raised
$479.3M
Stage
—
Founded
2025
Headcount
6
HQ
San Carlos, United States
Sector
Biotechnology
About
Onava is an AI-driven biotech reimagining how therapeutics are discovered. The company's platform integrates advanced deep learning models, high-throughput wet-lab assays, and human biological expertise to accelerate the design of functional, biologically relevant antibody candidates.
Funding history · 6 rounds · $479.3M total
6 events/rounds · $479.3M Total Funding: $479.3M in Private Equity
Aug 2026
E Round
$29.7M
pitchbook.com
Jun 2026
★ Korys★ COFIDES★ Bpifrance★ Asabys Partners★ Alta Life Sciences★ Mérieux Equity Partners★ Columbus Venture PartnersFundPlus NVYsios Capital
Jun 2025
★ AIP SeedL-BankBasisTechinnoWerftYaniv IzakiFamily OfficeSequoia CapitalHorizons VenturesMagma Venture PartnersMotorola Mobility Ventures
May 2024
★ L-Bank★ InnoWerft★ Heidelberg Startup Partners
Nov 2023
Sep 2023
Headcount over time
6 employees (2026-09) · 1 point
Offices
San Carlos, United States · HQ / main office
Q&A
- What is Onava's primary sector?
- Onava's primary sector is Digital Health.
- What is Onava's website?
- Onava's website is http://onava.ai.
Team · 5
Ido Calman
Founder · CEO & Co-Founder
Sharrol Bachas
Founder · CSO & Co-Founder
Hamed Alishahi
Founding Director of Screening Technologies
Puwanat Sangkhapreecha
Founding Scientist
Zeynep Onder
Founding VP, Operations & Partnerships
Sectors & technology
Primary sector
Biotechnology
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | onava.ai |
|---|
Identifiers & details
| Founded | 2025 |
|---|---|
| Employees (exact) | 6 |
Radar intelligence
Publications (Crossref)
| Works | 1 |
|---|